Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $239.6 million versus the consensus estimate of $226.26 million.

GUIDANCE:

Phibro Animal Health sees FY2022 EPS of $1.30-$1.39, versus the consensus of $1.36. Phibro Animal Health sees FY2022 revenue of $930-950 million, versus the consensus of $907.5 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.